In Brief NCCN Foundation announces recipients of 2026 Young Investigator Awards April 03, 2026Vol.52 No.13
In Brief Roswell Park brings lung healthcare initiative to indigenous communities across North America April 03, 2026Vol.52 No.13
In Brief Karmanos Cancer Institute becomes first free-standing cancer center to treat hemophilia B with new gene therapy April 03, 2026Vol.52 No.13
Clinical Roundup IMNN-001 improves median OS by over 14 months in newly diagnosed advanced ovarian cancer, phase II study shows April 03, 2026Vol.52 No.13
Clinical Roundup UVA scientists use AI to improve success rate for new drugs, reduce costs April 03, 2026Vol.52 No.13
Clinical Roundup Small molecule inhibitor blocks prostate cancer bone metastasis April 03, 2026Vol.52 No.13
Drugs & Targets FDA approves Ponlimsi to increase bone mass, including for breast and prostate cancer patients April 03, 2026Vol.52 No.13
Drugs & Targets FDA grants priority review to Elevar Therapeutics’s lirafugratinib as second-line cholangiocarcinoma treatment April 03, 2026Vol.52 No.13
